Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

4.320

-0.160 (-3.57%)

At close: Aug 24, 2026, 4:00 PM EDT

4.400

+0.080 (1.85%)

After-hours: Aug 24, 2026, 7:30 PM EDT

Camp4 Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-107.24	-80.4	-51.79	-49.29	-44.19
Depreciation & Amortization	1.82	1.64	1.7	1.68	0.88
Loss (Gain) From Sale of Assets	0.26	0.26	-	-	-
Asset Writedown & Restructuring Costs	0.58	0.49	-	-	-
Stock-Based Compensation	5.54	4	4.03	2.91	1.38
Other Operating Activities	57.7	31.45	1.83	1.82	1.69
Change in Accounts Payable	-0.1	-1.03	0.17	-1.12	1.33
Change in Unearned Revenue	14.51	17.12	0.39	-	-
Change in Other Net Operating Assets	-1.66	-3.08	-1.88	-0.15	0.37
Operating Cash Flow	-28.59	-29.55	-45.56	-44.16	-38.54
Operating Cash Flow Growth	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Capital Expenditures	-0.13	-0.28	-0.44	-0.68	-4.03
Sale of Property, Plant & Equipment	0.04	0.04	-	-	-
Investing Cash Flow	-0.09	-0.24	-0.44	-0.68	-4.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Long-Term Debt Issued	-	-	-	0.71	-
Long-Term Debt Repaid	-	-0.21	-0.82	-0.59	-0.09
Net Debt Issued (Repaid)	-0.13	-0.21	-0.82	0.12	-0.09
Issuance of Common Stock	57.63	57.57	76.47	0.19	0.06
Other Financing Activities	18.53	18.53	-3.98	-	-
Financing Cash Flow	76.03	75.89	71.66	0.3	100.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Cash Flow	47.35	46.09	25.66	-44.53	57.59

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	-28.72	-29.83	-46	-44.83	-42.57
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-681.21%	-852.83%	-7055.67%	-12809.43%	-
Free Cash Flow Per Share	-0.58	-0.98	-9.81	-113.51	-136.31
Levered Free Cash Flow	-12.83	-20.64	-26.52	-30.18	-
Unlevered Free Cash Flow	-12.83	-20.64	-26.52	-30.16	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Change in Working Capital	12.75	13.01	-1.33	-1.27	1.7

SEC Filings: 10-K · 10-Q